Modafinil effects on cognitive function in HIV+ patients treated for fatigue: A placebo controlled study

Journal of Clinical and Experimental Neuropsychology

Volumn 32, Issue 5, 2010, Pages 474-480

  McElhiney, Martin ^a,b   Rabkin, Judith ^a,b   Van Gorp, Wilfred ^a   Rabkin, Richard ^a,b  

^a Columbia University ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Clinical trial; Cognition; Fatigue; HIV; Modafinil

Indexed keywords

BENZHYDRYL DERIVATIVE; CD4 ANTIGEN; CENTRAL STIMULANT AGENT; MODAFINIL;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FATIGUE; FEMALE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LANGUAGE; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; RNA VIRUS; VIRUS LOAD;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIGENS, CD4; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION DISORDERS; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HIV INFECTIONS; HUMANS; LANGUAGE; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; RNA VIRUSES; SEVERITY OF ILLNESS INDEX; VIRAL LOAD; YOUNG ADULT;

EID: 77953015654     PISSN: 13803395     EISSN: 1744411X     Source Type: Journal    
DOI: 10.1080/13803390903201769     Document Type: Article

References (38)

1. Adler, C. H., Cavinoss, J. N., Hentz, J. G., Lind, M., & Tiede, J. (2003). Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. Movement Disorders, 18, 287-293.
2. Albert, S., & Rabkin, J. (2008). General health status, functioning, and disability measures. In A. J. Rush, M. First, & D. Blacker (Eds.), Handbook of psychiatric measures (pp. 107-123). Washington, DC: American Psychiatric Publishing.
3. Ballon, J., & Feifel, D. (2006). A systematic review of modafinil: Potential clinical uses and mechanisms of action. Journal of Clinical Psychiatry, 67, 554-566.
4. Benton, A. L., Lezak, M., Howieson, D., & Loring, D. (Eds.). (2004). Neuropsychological assessment (4th ed., pp. 519-520). New York: Oxford University Press.
5. Breitbart, W., McDonald, M., Rosenfeld, B., Norman, D., Monkman, N., & Passik, S. (1998). Fatigue in ambulatory AIDS patients. Journal of Pain & Symptom Management, 15, 159-167.
6. Broadbent, D. E., Cooper, P. F., Fitzgerald, P., & Parkes, K. (1982). The Cognitive Failures Questionnaire (CFQ) and its correlates. British Journal of Clinical Psychology, 21, 1016.
7. Brown, G. R. (1995). The use of methylphenidate for cognitive decline associated with HIV disease: Stimulant use in consultation patients. International Journal of Psychiatry in Medicine, 25, 21-37.
8. Cooper, M. R., Bird, H., & Steinberg, M. (2009). Efficacy and safety of modafinil in the treatment of cancer-related fatigue. Annals of Pharmacotherapy, 43, 721-725.
9. DeBattista, C., Lembke, A., Solvason, H. B., Ghebremichael, L. R., & Poirer, J. A. (2004). Prospective trial of modafinil as an adjunctive treatment of major depression. Journal of Clinical Psychopharmacology, 24, 87-90.
10. D'Elia, L., Satz, P., Uchiyama, C., & White, T. (1996). Color Trails Test. Odessa, FL: Psychological Assessment Resources.
11. Dinges, D. F., & Weaver, T. (2003). Effects of modafinil on sustained attention performance and quality of life in OSA patients with residual sleepiness while being treated with nCPAP. Sleep Medicine, 4, 393-402.
12. Durvasula, R., Norman, L., & Malow, R. (2009). Current perspectives on the neuropsychology of HIV. In C. Pope, R. White, & R. Malow (Eds.), HIV/AIDS: Global frontiers in prevention/intervention (pp. 177-190). New York: Routledge.
13. Golden, C. J. (1978). Stroop Word and Color Test: A manual for clinical and experimental uses. Wood Dale, IL: Stoetling Co.
14. Guy, W. (2008). Clinical Global Impressions (CGI) Scale. In A. Rush, M. First, & D. Blacker (Eds.), Handbook of psychiatric measures (2nd ed., pp. 90-92). Washington, DC: American Psychiatric Publishing.
15. Heaton, R., Marcotte, T., White, D., Ross, D., Meredith, K., Taylor, M., et al. (1996). Nature and vocational significance of neuropsychological impairment associated with HIV infection. Clinical Neuropsychologist, 10, 1-14.
16. Henderson, M., Safa, F., Easterbrook, P., & Hotopf, M. (2005). Fatigue among HIV-infected patients in the era of highly active antiretroviral therapy. HIV Medicine, 6, 347-352.
17. Hinkin, C., Castellon, S., Hardy, D. J., Farinpour, R., Newton, T., & Singer, E. (2001). Methylphenidate improves HIVassociated cognitive slowing. Journal of Neuropsychiatry and Clinical Neuroscience, 13, 248-254.
18. Hirshkowitz, M., & Black, J. (2007). Effect of adjunctive modafinil on wakefulness and quality of life in patients with excessive sleepiness-associated obstructive sleep apnoea/ hypopnoea syndrome: A 12-month open label extension study. CNS Drugs, 21, 407-416.
19. Justice, A. (1999). Sensitivity, specificity, reliability and clinical validity of provider-reported symptoms: A comparison with self-reported symptoms. Journal of Acquired Immune Deficiency Syndromes: JAIDS, 21, 126-133.
20. Koback, K., Skodol, A., & Bender, D. (2008). Diagnostic measures for adults. In A. J. Rush, M. First, & D. Blacker (Eds.), Handbook of psychiatric measures (pp. 35-60). Washington, DC: American Psychiatric Publishing.
21. Krupp, L., LaRocca, N., Muir-Nash, J., & Steinberg, A. (1989). The Fatigue Severity Scale. Archives of Neurology, 46, 1121-1123.
22. Leserman, J., Barrosso, J., Pence, B., Salahuddin, N., & Harmon, J. (2008). Trauma, stressful life events and depression predict HIV-related fatigue. AIDS Care, 20, 1258-1265.
23. Maj, M., D'Elia, L., Satz, P., Janssen, R., Zaudig, M., Uchiyama, C., et al. (1993). Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: The WHO study. Archives of Clinical Neuropsychology, 8, 123-135.
24. Matthews, C., & Klove, H. (1964). Instruction manual for the Adult Neuropsychology Test Battery. Madison, WI: University of Wisconsin Medical School.
25. Miller, E. N. (1990). California Computerized Assessment Battery (CalCAP) manual. Los Angeles: Norland Software.
26. Millikin, C. P., Rourke, S., Halman, M., & Power, C. (2003). Fatigue in HIV/AIDS is associated with depression and subjective neurocognitive complaints but not neuropsychological functioning. Journal of Clinical and Experimental Psychology, 25, 201-215.
27. Minzenberg, M. J., & Carter, C. S. (2008). Modafinil: A review of neurochemical actions and effects on cognition. Neuropsychopharmacology, 33, 1477-1502.
28. Moore, L. H., van Gorp, W., Hinkin, C., Stern, M., Swales, T., & Satz, P. (1997). Subjective complaints versus actual cognitive deficits in predominantly symptomatic HIV-1 seropositive individuals. Journal of Neuropsychiatry, 9, 37-44.
29. Norman, L., Basso, M., Kumar, A., & Malow, R. (2009). Neuropsychological consequences of HIV and substance abuse: A literature review and implications for treatment and future research. Current Drug Abuse Reviews, 2, 143-156.
30. Rabkin, J. G., Gordon, P., McElhiney, M., Rabkin, R., Chew, S., & Mitsumoto, H. (2009). Modafinil treatment of fatigue in patients with ALS: A placebo-controlled study. Muscle & Nerve, 39, 297-303.
31. Rammohan, K., Rosenberg, J., Lynn, D., Blumenfeld, A., Pollak, C., & Nagaraja, H. (2002). Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: A two centre Phase 2 study. Journal of Neurology, Neurosurgery, & Psychiatry, 72, 179-183.
32. Randall, D. C., Shneerson, J., Plaha, K., & File, S. (2002). Modafinil affects mood, but not cognitive function, in healthy young volunteers. Human Psychopharmacology, 18, 163-173.
33. Saavedra-Velez, C., Yusim, A., Anbarasan, D., & Lindenmayer, J. P. (2009). Modafinil as an adjunctive treatment of sedation, negative symptoms and cognition in schizophrenia: A critical review. Journal of Clinical Psychiatry, 70, 104-112.
34. Volkow, N., Fowler, J., Logan, J., Alexoff, D., Zhu, W., Telang, F., et al. (2009). Effects of modafinil on dopamine and dopamine transporters in the male human brain: Clinical implications. JAMA: The Journal of the American Medical Association, 301, 1148-1154.
35. Wechsler, D. (1997). Wechsler Adult Intelligence Scale-Third Edition (WAIS-III). San Antonio, TX: The Psychological Corporation.
36. Wilkins, L. H., Robertson, K., Snyder, C., Robertson, W., van der Horst, C., & Hall, C. D. (1991). Implications of selfreported cognitive and motor dysfunction in HIV-positive patients. American Journal of Psychiatry, 148, 641-643.
37. Williams, J. B. W. (2008). Mental health status, functioning and disabilities measures. In A. J. Rush, M. First, & D. Blacker (Eds.), Handbook of psychiatric measures (pp. 83-105). Washington, DC: American Psychiatric Publishing.
38. Yonkers, K., & Samson, J. (2008). Mood disorders measures. In A. J. Rush, M. First, & D. Blacker (Eds.), Handbook of psychiatric measures (pp. 499-528). Washington, DC: American Psychiatric Publishing.